Perspective Therapeutics (CATX) Other Accumulated Expenses (2011 - 2023)
Perspective Therapeutics recorded quarterly Other Accumulated Expenses of $480000.0 in Q4 2023, up 1900.0% quarter-over-quarter from $24000.0 in Q3 2023, and down 15.94% year-over-year from $571000.0 in Q4 2022.
Perspective Therapeutics' Other Accumulated Expenses history runs 13 years deep, the most recent figure standing at $480000.0 for Q4 2023.
- In Q4 2023, Other Accumulated Expenses fell 15.94% year-over-year to $480000.0; the TTM figure through Dec 2023 stood at $480000.0 (down 15.94% YoY), while the FY2023 annual figure was $480000.0, down 15.94% from the prior year.
- Other Accumulated Expenses came in at $480000.0 for Q4 2023 at Perspective Therapeutics, up from $24000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $571000.0 in Q4 2022 to a low of $15000.0 in Q1 2023.
- A 5-year average of $127300.0 and a median of $96500.0 in 2020 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses jumped 454.37% in 2022 and slumped 84.04% in 2023, its largest moves.
- Perspective Therapeutics' Other Accumulated Expenses stood at $89000.0 in 2019, then climbed by 13.48% to $101000.0 in 2020, then rose by 1.98% to $103000.0 in 2021, then surged by 454.37% to $571000.0 in 2022, then slipped by 15.94% to $480000.0 in 2023.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $480000.0, $24000.0, and $20000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 480,000.00 |
| Sep 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2022 | 571,000.00 |
| Sep 30, 2022 | 125,000.00 |
| Jun 30, 2022 | 120,000.00 |
| Mar 31, 2022 | 94,000.00 |
| Dec 31, 2021 | 103,000.00 |
| Sep 30, 2021 | 102,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 99,000.00 |
| Dec 31, 2020 | 101,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 94,000.00 |
| Mar 31, 2020 | 87,000.00 |
| Dec 31, 2019 | 89,000.00 |
| Sep 30, 2019 | 83,000.00 |
| Jun 30, 2019 | 74,000.00 |
| Mar 31, 2019 | 65,000.00 |
| Dec 31, 2018 | 55,000.00 |
| Sep 30, 2018 | 45,000.00 |
| Jun 30, 2018 | 37,000.00 |
| Mar 31, 2018 | 28,000.00 |
| Dec 31, 2017 | 19,000.00 |
| Sep 30, 2017 | 11,000.00 |
| Jun 30, 2017 | 125,000.00 |
| Mar 31, 2017 | 203,000.00 |
| Dec 31, 2016 | 195,000.00 |
| Sep 30, 2016 | 189,000.00 |
| Jun 30, 2016 | 177,000.00 |
| Mar 31, 2016 | 164,544.00 |
| Dec 31, 2015 | 153,500.00 |
| Jun 30, 2015 | 129,500.00 |
| Jun 30, 2014 | 141,592.00 |
| Mar 31, 2014 | 130,301.00 |
| Dec 31, 2013 | 46,973.00 |
| Sep 30, 2013 | 112,000.00 |
| Jun 30, 2013 | 25,305.00 |
| Mar 31, 2013 | 27,500.00 |
| Dec 31, 2012 | 76,000.00 |
| Sep 30, 2012 | 64,000.00 |
| Jun 30, 2012 | 52,000.00 |
| Mar 31, 2012 | 86,666.00 |
| Dec 31, 2011 | 132,060.00 |
| Sep 30, 2011 | 101,537.00 |
| Jun 30, 2011 | 98,159.00 |